NanoMosaic to receive “Emerging MedTech Company of the Year” award

NanoMosaic to receive “Emerging MedTech Company of the Year” award

by admin December 14, 2022 December 14, 2022 No comments

NanoMosaic, the leader in next-generation digital proteomic interrogation technology, won the prestigious NEVY, New England Venture Capital award, for, “Emerging MedTech Company of the Year.” The award was presented to NanoMosaic at the sold-out awards ceremony at the House of Blues in Boston

The company, which announced its oversubscribed Series A round of $40.75MM in November 2021

  • Has multiple published peer reviewed papers with prestigious hospitals and thought leaders
  • Had An IRB approved study at Massachusetts General Hospital that was based on the Tessie to identify biomarkers for post-operative delirium
  • Is working with the FDA on 510K approval for its system for diagnostic testing implementation
  • Has developed an impressive, and rapidly growing system install base in the life science research field
  • Is completing construction on a 32K square foot facility on Winter Street in Waltham, MA in Q1 2023

The NanoMoasic Tessie™ platform allows for streamlined sample preparation, whereby plasma is diluted and deposited directly onto the Tessie chip for analysis with results for 96 samples obtained in ~13 minutes.  The simplicity in sample preparation removes molecular biases and provides a straightforward and seamless workflow for lab and diagnostic technicians.

Leave comments

Your email address will not be published.*

<br><br>You may use these <abbr title="HyperText Markup Language">HTML</abbr> tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Supportscreen tag